Beam Therapeutics
Breaking new ground to advance science with the potential to change lives | Beam Therapeutics. Scroll down for more. Base Editing Applications. Base editing is an emerging class of investigational precision genetic medicines designed to overcome the limitations of existing approaches and expand the potential of genetic medicine.
Beam Therapeutics Inc. (BEAM) Stock Price, News, Quote ...
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.
Beam Therapeutics Reports Third Quarter 2024 Financial ...
Nov 5, 2024 · Beam has nominated a development candidate for its ESCAPE technology comprised of two investigational drug products: BEAM-103, an anti-CD117 monoclonal antibody (mAb), and BEAM-104, a cell therapy ...
Beam Therapeutics Reports Third Quarter 2024 Financial ...
Nov 5, 2024 · Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities.
About Us - Beam Therapeutics
Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing lifelong cures to patients suffering from serious diseases. The Beam Team is:
Investor Overview | Beam Therapeutics
Jun 6, 2024 · Beam Therapeutics is a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.
Pipeline - Beam Therapeutics
Approach: Activation of fetal hemoglobin. BEAM-101 is an investigational therapy that produces base edits designed to potentially alleviate the effects of sickle cell disease by mimicking genetic variants seen in individuals who have hereditary persistence of fetal hemoglobin.
- Some results have been removed